Our Mission

The Team Drea Foundation supports bold, innovative research to find a cure or effective treatment for ALS.

We see raising awareness about this devastating disease as an opportunity to inspire people to live bravely, love joyfully, and appreciate the gift of life.

Our Founder

Andrea Lytle Peet was diagnosed with ALS in 2014 at the age of 33. In eight months, she went from completing a 70.3-mile half Ironman triathlon to walking with a cane.

Remarkably, she has continued to participate in races. Since diagnosis, she has completed 35+ marathons, half marathons or triathlons on her recumbent trike. Her new goal is to complete a marathon in all 50 states.

Go On, Be Brave. Make A World Without ALS

States + Canada, and the U.K
Donations Raised
Happy birthday to my beautiful mama! We took our @catrike twins out for a spin!! 💚💚 ...
View on Facebook
Medal Monday! Thank to Shannon @bodysensephysicaltherapy for these GORGEOUS photos! 💚💪💚💪 ...
View on Facebook

1 week ago

Team Drea Foundation
Marathon #26 in MD in the books — @sbymarathon ✅ Maiden marathon for the new folding @catrike 💚 It did great, the engine could use a little work 🤣.Many thanks to Shannon from @bodysensephysicaltherapy for getting up at 3am to come spectate! And of course DP who I could not do these without 🥰 Feels good to be back out here after a 4mo covid/winter hiatus 💚💪 Only 19 left this year...you think I’m joking, I’m not.😅 ...
View on Facebook

Please listen to the medical ethicist @SecMandyCohen @NC_Governor @ncdhhs @meganranney

When it Comes to Vaccination, the Terminally Ill Shouldn’t Be Forgotten—They Should Be Prioritized
by @JamieDWebb in @arcdigi


We're begging you @ncdhhs, @SecMandyCohen, @NC_Governor -- we won't survive if we get covid. Please stop putting healthy people in front of us.

Load More...

About ALS

Amyotrophic lateral sclerosis (aka ALS or Lou Gehrig’s disease) is a progressive neurological disease that affects the nerve cells in the brain and spinal cord. When motor neurons that connect nerves and muscles die, people lose the ability to initiate and control muscle movement. Without stimulation, muscles become weak and atrophy. Most people with ALS become totally paralyzed as they lose the ability to walk, talk, eat, swallow, and breathe.

Every 90 minutes, someone with ALS dies and another person is diagnosed.

The average age of diagnosis is 55; however, cases of ALS also appear in people in their 20s and 30s.

Military veterans are twice as likely to develop ALS as the general population. Athletes also seem to be more susceptible. No one is sure why.

The average life expectancy of a person with ALS is 2-5 years. 20% live 5 years or more; 10% percent live more than 10 years.

The only approved drug for ALS (riluzole), only extends life expectancy by 2-3 months.